Ubiquitin proteasome pathway: implications and advances in cancer therapy.

Ubiquitin proteasome pathway: implications and advances in cancer therapy.

Item
http://www.wikidata.org/entity/Q34446282
Mapping and structural dissection of human 20 S proteasome using proteomic approachesThe Ubiquitin Proteasome Pathway (UPP) in the regulation of cell cycle control and DNA damage repair and its implication in tumorigenesisMG132, a proteasome inhibitor, induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion.Targeted therapies in small-cell lung cancer.Follicular thyroid cancer cell growth inhibition by proteosome inhibitor MG132MG-132 inhibits carcinoid growth and alters the neuroendocrine phenotype.Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitorsNrf2 silencing to inhibit proteolytic defense induced by hyperthermia in HT22 cells.Antitrypanosomal activities of proteasome inhibitors.Treatment with p38 inhibitor intensifies the death of MG132-treated As4.1 juxtaglomerular cells via the enhancement of GSH depletion.Synthetic lethal short hairpin RNA screening reveals that ring finger protein 183 confers resistance to trametinib in colorectal cancer cells.Expression of protein gene product 9.5 (PGP9.5)/ubiquitin-C-terminal hydrolase 1 (UCHL-1) in human myeloma cells.Calcium- and proteasome-dependent degradation of the JNK scaffold protein islet-brain 1.15-Deoxy-delta12,14-prostaglandin J2-induced apoptosis does not require PPARgamma in breast cancer cells.Evidence for the Critical Roles of NF-κB p65 and Specificity Proteins in the Apoptosis-Inducing Activity of Proteasome Inhibitors in Leukemia Cells.Mitogen-activated protein kinase inhibitors differently affect the growth inhibition and death of a proteasome inhibitor, MG132-treated human pulmonary fibroblast cells.
P2860

Ubiquitin proteasome pathway: implications and advances in cancer therapy.

Item
http://www.wikidata.org/entity/Q34446282
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Ubiquitin proteasome pathway: implications and advances in cancer therapy.
@ast
Ubiquitin proteasome pathway: implications and advances in cancer therapy.
@en
Ubiquitin proteasome pathway: implications and advances in cancer therapy.
@nl
type
label
Ubiquitin proteasome pathway: implications and advances in cancer therapy.
@ast
Ubiquitin proteasome pathway: implications and advances in cancer therapy.
@en
Ubiquitin proteasome pathway: implications and advances in cancer therapy.
@nl
prefLabel
Ubiquitin proteasome pathway: implications and advances in cancer therapy.
@ast
Ubiquitin proteasome pathway: implications and advances in cancer therapy.
@en
Ubiquitin proteasome pathway: implications and advances in cancer therapy.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Ubiquitin proteasome pathway: implications and advances in cancer therapy.
@en
P2093
P304
P31
P356
10.1016/S0960-7404(01)00018-4
P433
P478
P577
P698
P921